Try our mobile app

General information

Sistema PJSC FC is a publicly-listed investment company incorporated in Russia. The Company owns a diverse set of public and private companies which it holds in two distinct portfolios: Core assets and Developing assets.
  • Dividend yield for the last twelve months 2.3%
  • Free cash flow yield -58.6% (LTM)
  • Share price is 75.7% higher than minimum and 52.5% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (4.9x vs
    )

Key Financials (Download financials)

Ticker: AFKS
Share price, RUB:  (+0.1%)18.0495
year average price 16.56  


year start price 13.01 2023-03-02

min close price 13.01 2023-03-02

max close price 18.93 2023-08-03

current price 17.99 2024-02-29
Common stocks: 9 650 000 000

Dividend Yield:  2.3%
FCF Yield LTM: -58.6%
EV / LTM EBITDA: 4.9x
EV / EBITDA annualized: 5.1x
Target EV / EBITDA (hist percentile):
Express share price potential:
EV / LTM EBITDA mutiple calculation
Market Cap (m RUB): 174 178
Net Debt (m RUB): 1 346 942
EV (Enterprise Value): 1 521 120
EBITDA LTM (m RUB): 312 355
EV / LTM EBITDA: 4.9x
Average daily trading volume for the week, RUB mln: 545.30

Revenue and EBITDA

Quarterly values (m RUB)

Change (y/y)

Cash Flow

FCF (m RUB), before FX effects elimination

Net Debt / Cash and Equivalents (m RUB)

Share price and dividends (Download history)

Share price

Payment RUB per share

Multiple and potential

EV / LTM EBITDA and 50% percentile

Potential dynamics

Daily trade volumes

Millions of RUB

Valuation through assets (as of the end of 2023 q2)


Sistema PJSC FC has stakes in the following companies

Company Ticker Share Cap EBITDA LTM Net Debt
Segezha Group SGZH 72.0% 62 062 11 008 136 741
MTS MTSS 50.3% 491 539 207 069 415 959
OZON OZON 32.4% 662 128
Etalon ETLN 29.8% 37 720
Influence at AFKS 517 695 218 077 552 700
mln RUB
 
         Net Debt AFKS 1 320 542
         Net Debt in listed companies 552 700
      Net Debt in not listed companies 767 842
 
         EBITDA LTM AFKS 307 592
         EBITDA LTM in listed companies 218 077
         EBITDA LTM in not listed companies 89 515
      EV evaluation in not listed companies (x5) 447 575
 
      Binnopharm Cap revaluation 41 600
 
   Cap in not listed companies, min -300k -278 667
   Cap in listed companies 517 695
 
AFKS Cap evaluation through assets 239 028
AFKS Cap 174 380
 
Current price discount 27.0%
Historical price discount 2.8%
 
Growth potential (0.973 / 0.730 - 1) +33.3%
chart technology by TradingView
chart technology by TradingView
More information for subscribed users:
detailed calculation of
Potential and Created Value,
commodities affecting the company